These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36705433)

  • 1. Predictors of Treatment Completion among Women Receiving Integrated Treatment for Comorbid Posttraumatic Stress and Substance Use Disorders.
    Killeen TK; Wen CC; Neelon B; Baker N
    Subst Use Misuse; 2023; 58(4):500-511. PubMed ID: 36705433
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder.
    Vrana C; Killeen T; Brant V; Mastrogiovanni J; Baker NL
    Contemp Clin Trials; 2017 Oct; 61():108-114. PubMed ID: 28765006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trauma-Integrated Mindfulness-Based Relapse Prevention for Women with Comorbid Post-Traumatic Stress Disorder and Substance Use Disorder: A Cluster Randomized Controlled Feasibility and Acceptability Trial.
    Somohano VC; Bowen S
    J Integr Complement Med; 2022 Sep; 28(9):729-738. PubMed ID: 35648046
    [No Abstract]   [Full Text] [Related]  

  • 4. Formal mindfulness practice predicts reductions in PTSD symptom severity following a mindfulness-based intervention for women with co-occurring PTSD and substance use disorder.
    Somohano VC; Kaplan J; Newman AG; O'Neil M; Lovejoy T
    Addict Sci Clin Pract; 2022 Sep; 17(1):51. PubMed ID: 36114577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes?
    Jeffirs SM; Jarnecke AM; Flanagan JC; Killeen TK; Laffey TF; Back SE
    Drug Alcohol Depend; 2019 Jun; 199():70-75. PubMed ID: 31009834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of trauma-focused and non-trauma-focused psychotherapy for PTSD among veterans with comorbid substance use disorders: Protocol & rationale for a randomized clinical trial.
    Kehle-Forbes SM; Nelson D; Norman SB; Schnurr PP; Shea MT; Ackland PE; Meis L; Possemato K; Polusny MA; Oslin D; Hamblen JL; Galovski T; Kenny M; Babajide N; Hagedorn H
    Contemp Clin Trials; 2022 Sep; 120():106876. PubMed ID: 35987487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of co-occurring posttraumatic stress disorder and substance use: Does order of onset influence outcomes?
    Bountress KE; Badour C; Flanagan J; Gilmore AK; Back SE
    Psychol Trauma; 2018 Nov; 10(6):662-665. PubMed ID: 28771018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial.
    Ruglass LM; Lopez-Castro T; Papini S; Killeen T; Back SE; Hien DA
    Psychother Psychosom; 2017; 86(3):150-161. PubMed ID: 28490022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance Abuse-Related Self-Stigma in Women with Substance Use Disorder and Comorbid Posttraumatic Stress Disorder.
    Melchior H; Hüsing P; Grundmann J; Lotzin A; Hiller P; Pan Y; Driessen M; Scherbaum N; Schneider B; Hillemacher T; Stolzenburg S; Schomerus G; Schäfer I;
    Eur Addict Res; 2019; 25(1):20-29. PubMed ID: 30625465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations Between Lifetime Panic Attacks, Posttraumatic Stress Disorder, and Substance Use Disorders in a Nationally Representative Sample.
    Blakey SM; Campbell SB; Simpson TL
    J Dual Diagn; 2022; 18(1):21-32. PubMed ID: 34965200
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of trauma characteristics on post-traumatic stress disorder and substance use disorder outcomes across integrated and substance use treatments.
    Fitzpatrick S; Saraiya T; Lopez-Castro T; Ruglass LM; Hien D
    J Subst Abuse Treat; 2020 Jun; 113():107976. PubMed ID: 32059924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal dynamics of symptom change among veterans receiving an integrated treatment for posttraumatic stress disorder and substance use disorders.
    Badour CL; Flanagan JC; Allan NP; Gilmore AK; Gros DF; Killeen T; Korte KJ; Brown DG; Kolnogorova K; Back SE
    J Trauma Stress; 2022 Apr; 35(2):546-558. PubMed ID: 34773928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans.
    Back SE; Killeen T; Badour CL; Flanagan JC; Allan NP; Ana ES; Lozano B; Korte KJ; Foa EB; Brady KT
    Addict Behav; 2019 Mar; 90():369-377. PubMed ID: 30529244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lagged effects of substance use on PTSD severity in a randomized controlled trial with modified prolonged exposure and relapse prevention.
    Hien DA; Smith KZ; Owens M; López-Castro T; Ruglass LM; Papini S
    J Consult Clin Psychol; 2018 Oct; 86(10):810-819. PubMed ID: 30265040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating posttraumatic stress disorder in substance use disorder patients with co-occurring posttraumatic stress disorder: study protocol for a randomized controlled trial to compare the effectiveness of different types and timings of treatment.
    Lortye SA; Will JP; Marquenie LA; Goudriaan AE; Arntz A; de Waal MM
    BMC Psychiatry; 2021 Sep; 21(1):442. PubMed ID: 34493253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment receipt patterns among individuals with co-occurring posttraumatic stress disorder (PTSD) and substance use disorders.
    Simpson TL; Hawrilenko M; Goldberg S; Browne K; Lehavot K; Borowitz M
    J Consult Clin Psychol; 2020 Nov; 88(11):1039-1051. PubMed ID: 32790452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of substance use disorders: Effects on patients with higher or lower levels of PTSD symptoms.
    Wieferink CEM; de Haan HA; Dijkstra BAG; Fledderus M; Kok T
    Addict Behav; 2017 Nov; 74():122-126. PubMed ID: 28622616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A treatment development study of a cognitive and mindfulness-based therapy for adolescents with co-occurring post-traumatic stress and substance use disorder.
    Fortuna LR; Porche MV; Padilla A
    Psychol Psychother; 2018 Mar; 91(1):42-62. PubMed ID: 28815876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Wrong Doors: Findings from a Critical Review of Behavioral Randomized Clinical Trials for Individuals with Co-Occurring Alcohol/Drug Problems and Posttraumatic Stress Disorder.
    Simpson TL; Lehavot K; Petrakis IL
    Alcohol Clin Exp Res; 2017 Apr; 41(4):681-702. PubMed ID: 28055143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders?
    Lancaster CL; Gros DF; Mullarkey MC; Badour CL; Killeen TK; Brady KT; Back SE
    Behav Cogn Psychother; 2020 Jan; 48(1):38-53. PubMed ID: 31010449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.